The study of Yasuda et al. [80] revealed that the normal human cervix and malignant endometrial and ovarian tumors produce EPO and EPOR, and that the tumor cells and capillary ECs themselves are sites responsive to the EPO. Here, EPOR is linked to neoplasm.